PATRICK J MAHAFFY
CIK 1266569 · See Remarks · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
41
Lifetime Open-Market Net
$798.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDCXW | Director | — | $0.50 | — | $0 | 3 | 2026-06-04 |
| Clovis Oncology, Inc. (CLVS) Delisted | See Remarks | 920,187 | $0.08 | $74.7K | $798.6K | 14 | 2022-03-03 |
| FLXN | Director | 0 | $25.05 | $0 | $0 | 11 | 2021-11-19 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | Director | — | — | — | $0 | 9 | 2017-07-18 |
| PHARMION CORP (PHRM) Delisted | CEO, President | 357,623 | — | — | $0 | 3 | 2008-03-05 |
Recent Filings · Page 2 of 5
41 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-08-29 | FLXN | Exer (M) | +30,824 | $4.9K | EDGAR |
| 2019-08-19 | Clovis Oncology, Inc. (CLVS) Delisted | Buy (P) | +50,000 | $279.6K | EDGAR |
| 2019-06-21 | FLXN | Grant (A) | — | $0 | EDGAR |
| 2019-02-04 | Clovis Oncology, Inc. (CLVS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-21 | FLXN | Grant (A) | — | $0 | EDGAR |
| 2018-03-02 | Clovis Oncology, Inc. (CLVS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-07-27 | FLXN | Grant (A) | — | $0 | EDGAR |
| 2017-07-18 | Orexigen Therapeutics, Inc. (OREX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-28 | Clovis Oncology, Inc. (CLVS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-09-19 | Clovis Oncology, Inc. (CLVS) Delisted | Other (J) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.